Komori
Transgenic Group (2342) · InitiativeRestated

Expansion of orders for self-collected HPV co-testing

First written in FY2016. 13 of 15 entries say "Restated". Latest entry: FY2020.

15entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018-Q2RestatedFY2019-Q1 – FY20202016: 320162017: 420172018: 320182019: 320192020: 22020
Same theme, other companies
Entry into the self-administered HPV testing services businessA theme 2 companies write about · 0 as a headwind · 2 as a tailwind

0 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2020RestatedAnnual report

    「To contribute to the early detection of cervical cancer, the company focused on educational and sales activities concerning the usefulness of self-collected HPV testing, a cervical cancer risk test, and promoted the conclusion of outsourced testing services contracts with local governments working to expand cervical cancer screening.」

    The company continues educational and sales activities for self-collected HPV testing and efforts to conclude outsourced testing services contracts with local governments.
  2. FY2020-Q3RestatedAnnual report

    「To contribute to the early detection of cervical cancer, the company focused on educational and sales activities concerning the usefulness of self-collected HPV testing, a cervical cancer risk test, and promoted the conclusion of outsourced testing services contracts with local governments working to expand cervical cancer screening.」

    The company continues educational and sales activities for self-collected HPV testing and efforts to conclude outsourced testing services contracts with local governments.
  3. FY2020-Q2RestatedAnnual report

    「The company also sought to secure medical institutions adopting its comprehensive cancer clinical sequencing service. To contribute to the early detection of cervical cancer, it focused on educational and sales activities concerning the usefulness of self-collected HPV testing, a cervical cancer risk test, and promoted the conclusion of outsourced testing services contracts with local governments working to expand cervical cancer screening.」

    The company continues educational and sales activities for self-collected HPV testing and efforts to conclude outsourced testing services contracts with local governments.
  4. FY2019RestatedAnnual report

    「To expand its business base, the company will further strengthen sales of self-collected HPV testing, a cervical cancer risk test.」

    The company continues to pursue business-base expansion by strengthening sales of self-collected HPV testing.
  5. FY2019-Q3RestatedAnnual report

    「To contribute to the early detection of cervical cancer, the company focused on educational and sales activities concerning the usefulness of self-collected HPV testing, a cervical cancer risk test, and promoted the conclusion of outsourced testing services contracts with local governments working to expand cervical cancer screening.」

    The company continues educational and sales activities for self-collected HPV testing and efforts to conclude outsourced testing services contracts with local governments.
  6. FY2019-Q2RestatedAnnual report

    「To contribute to the early detection of cervical cancer, the company focused on educational and sales activities concerning the usefulness of HPV risk testing and promoted the conclusion of outsourced testing services contracts with local governments working to expand cervical cancer screening.」

    The company continues educational and sales activities concerning the usefulness of HPV testing and efforts to conclude outsourced testing services contracts with local governments. It does not state that any contracts have been completed.
  7. FY2019-Q1RestatedAnnual report

    「To contribute to the early detection of cervical cancer, the company focused on educational and sales activities concerning the usefulness of HPV testing and promoted the conclusion of outsourced testing services contracts with local governments working to expand cervical cancer screening.」

    The company continues educational and sales activities for HPV testing and efforts to conclude outsourced testing services contracts with local governments. It does not state that any new contracts have been completed.
  8. FY2018-Q3AdvancedAnnual report

    「To promote the early detection of cervical cancer, the company concluded a contract with a local government for outsourced testing services for self-collected HPV testing and focused on sales and expanding orders for pathology diagnostic services.」

    The company reports progress in its order base through the specific development of concluding an outsourced testing services contract with a local government for self-collected HPV testing.
  9. FY2018-Q2RestatedAnnual report

    「To promote the early detection of cervical cancer, the company focused on sales and expanding orders for HPV co-testing services, including self-collection, and pathology diagnostic services enhanced by the web-based pathology reporting system launched in the previous fiscal year.」

    The company continues to expand sales and orders for HPV co-testing services, including self-collection, and services enhanced by the web-based pathology reporting system.
  10. FY2018-Q1RestatedAnnual report

    「To promote the early detection of cervical cancer, the company focused on sales and expanding orders for HPV co-testing services, including self-collection, and pathology diagnostic services enhanced by the web-based pathology reporting system launched in the previous fiscal year.」

    The company continues to expand sales and orders for HPV co-testing services, including self-collection.
  11. FY2017RestatedAnnual report

    「During the fiscal year, the company focused on sales and expanding orders for HPV co-testing services, including self-collection, to promote the early detection of cervical cancer.」

    The company continues to prioritize sales and expanding orders for HPV co-testing services, including self-collection.
  12. FY2017-Q3RestatedAnnual report

    「During the nine-month period ended the third quarter, the company focused on expanding orders for HPV co-testing services, including self-collection, to promote the early detection of cervical cancer.」

    The company continues to prioritize expanding orders for HPV co-testing services, including self-collection.
  13. FY2017-Q2RestatedAnnual report

    「During the six-month period ended the second quarter, the company focused on expanding orders for HPV co-testing services, including self-collection, to promote the early detection of cervical cancer.」

    The company continues to prioritize expanding orders for HPV co-testing services, including self-collection.
  14. FY2017-Q1RestatedAnnual report

    「During the three-month period ended the first quarter, the company focused on expanding orders for HPV co-testing services, including self-collection, to promote the early detection of cervical cancer.」

    The company continues to prioritize expanding orders for HPV co-testing services, including self-collection.
  15. FY2016First statedAnnual report

    「From October last year, the company began offering self-collected HPV co-testing for people unable to undergo gynecological screening.」

    The company began offering self-collected HPV co-testing for people unable to undergo gynecological screening and aims to expand orders.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Transgenic Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion of orders for self-collected HPV co-testing | TRANSGENIC GROUP INC. (2342) | Komori